An Autonomic Neuroprosthesis: Noninvasive Electrical Spinal Cord Stimulation Restores Autonomic Cardiovascular Function in Individuals with Spinal Cord Injury. by Phillips, Aaron A et al.
UCLA
UCLA Previously Published Works
Title
An Autonomic Neuroprosthesis: Noninvasive Electrical Spinal Cord Stimulation Restores 
Autonomic Cardiovascular Function in Individuals with Spinal Cord Injury.
Permalink
https://escholarship.org/uc/item/0hw6598j
Journal
Journal of neurotrauma, 35(3)
ISSN
0897-7151
Authors
Phillips, Aaron A
Squair, Jordan W
Sayenko, Dimitry G
et al.
Publication Date
2018-02-01
DOI
10.1089/neu.2017.5082
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
An Autonomic Neuroprosthesis:
Noninvasive Electrical Spinal Cord Stimulation
Restores Autonomic Cardiovascular Function
in Individuals with Spinal Cord Injury
Aaron A. Phillips,1 Jordan W. Squair,1 Dimitry G. Sayenko,2 V. Reggie Edgerton,2–5
Yury Gerasimenko,2,6,* and Andrei V. Krassioukov1,*
Abstract
Despite autonomic dysfunction after spinal cord injury (SCI) being the major cause of death and a top health priority, the
clinical management options for these conditions are limited to drugs with delayed onset and nonpharmacological inter-
ventions with equivocal effectiveness. We tested the capacity of electrical stimulation, applied transcutaneously over the
spinal cord, to manage autonomic dysfunction in the form of orthostatic hypotension after SCI. We assessed beat-by-beat
blood pressure (BP), stroke volume, and cardiac contractility (dP/dt; Finometer), as well as cerebral blood flow (transcranial
Doppler) in 5 individuals with motor-complete SCI (4 cervical, 1 thoracic) during an orthostatic challenge with and without
transcutaneous electrical stimulation applied at the TVII level. During the orthostatic challenge, all individuals experienced
hypotension characterized by a 37– 4mm Hg decrease in systolic BP, a 52– 10% reduction in cardiac contractility, and a
23– 6% reduction in cerebral blood flow (all p< 0.05), along with severe self-reported symptoms. Electrical stimulation
completely normalized BP, cardiac contractility, cerebral blood flow, and abrogated all symptoms. Noninvasive transcuta-
neous electrical spinal cord stimulation may be a viable therapy for restoring autonomic cardiovascular control after SCI.
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Introduction
Over the past 10 years, we have come to realize that elec-trical stimulation of the spinal cord caudal to the injury has
the capacity to both directly excite spinal cord neurons and also
modulate spinal circuity.1–6 Although the recovery of walking has
been the focus of the vast majority of research into electrical stim-
ulation after spinal cord injury (SCI), the recovery of normal auto-
nomic cardiovascular function is consistently reported to be more
urgently desired by people living with SCI.7 Based on the present
understanding of somatovisceral integration within the spinal cord, it
is plausible that electrical spinal cord stimulation can acutely excite
and/or modulate spinal autonomic circuits to rapidly normalize
cardiovascular function after SCI.7 In support of this contention,
some early work in uninjured individuals have observed that elec-
trical spinal stimulation can elicit acute cardiovascular effects, in-
cluding altered blood flow and potentially cardiac function.8–10
Autonomic dysfunction permeates into all aspects of life after
SCI, with particularly insidious cardiovascular consequences.7
Orthostatic hypotension (OH) is a major concern after SCI and is
defined as a 20mm Hg or more decrease in systolic blood pressure
(BP).7 The majority of those living with SCI experience OH, which
often leads to the loss of consciousness,7 and has been shown to
result in impaired cognitive function.7,11 Over the long term, re-
petitive exposure to OH is associated with declining cardiovascular/
cerebrovascular health12–14 and likely underlies the 3- to 4-fold
elevated odds and risk of cardiovascular and cerebrovascular dis-
eases after SCI, which are the primary causes of death.15,16 Phar-
macological and nonpharmacological options for managing OH
are limited. Alpha-agonist administration 1 h before an episode of
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OH is capable of acutely improving BP as well as integrated cardiac
and cerebrovascular functions.7,11,17,18 Although pharmacological
approaches certainly have a role clinically, they have significant
limitations given that they require a number of minutes/hours to
become active, and then persist for hours, with significant side
effects.19 Conversely, OH experienced by people with SCI is often
unexpected and much more transient, occurring in just minutes.7
One recent study focused on restoring lower-limb function through
electrical spinal cord stimulation mentioned anecdotes indicating
that autonomic function may be acutely improved in their spinal
cord–injured participants, but did not provide any supporting data.5
No study has evaluated the potential for electrical spinal cord
stimulation to restore autonomic cardiovascular function after SCI.
Herein, we introduce a novel strategy to manage a cardio-
vascular dysfunction system using noninvasive transcutaneous
electrical spinal cord stimulation after SCI. We reasoned that
stimulation of the thoracic spinal cord, where sympathetic pre-
ganglionic neurons cell bodies are located, would elicit acute in-
creases in BP, cerebral blood flow, and cardiac function when they
were dangerously reduced because of orthostasis.
Methods
Four individuals all sustained motor-complete cervical injury
(C5 American Spinal Injury Association Impairment Scale [AIS]-
B; C5 AIS-B; C5 AIS-A; C6 AIS-A) whereas the fifth was motor
complete at the T2 level AIS-A (1 female), all occurring at least 3
years before the assessments. All participants were between 23 and
32 years of age and instructed to prepare for the testing day as
previously described,20 and provided written informed consent
in accord with the University of California, Los Angeles (Los
Angeles, CA) Institutional Review Board, who approved this study.
Participants were tested over a 1-h protocol that consisted of at least
15min of resting in the supine position, while being outfitted with
assessment equipment, followed by at least 10min of supine rest,
which preceded a progressive orthostatic challenge that has been
previously described and shown to be a reliable test of OH.21
Participants were asked to rank their symptoms of nausea/
dizziness 1–10 (10 being most severe) each minute of the test. After
BP decreased sufficiently to clinically indicate OH (i.e., a 20mm
Hg decrease in systolic BP), transcutaneous stimulation was
FIG. 1. Vignette: Electrical spinal cord stimulation improved integrated cardiovascular responses to orthostatic challenge. Participant:
female, 32 years of age, spinal cord injury at C6 (AIS-A), injured August 2009. Left blue inlet: Although experiencing severe orthostatic
hypotension when assuming upright posture, electrical stimulation at the TVII level restored blood pressure, cerebral blood flow, cardiac
function, and symptoms of orthostatic intolerance to supine levels. Note: Increasing current (20, 40, and 50mA) resulted in step-wise
increases in cardiovascular function. Right red inlet: electromyography recording of lower limbs shows that skeletal muscle contraction
was not activating the skeletal muscle pump of the venous vasculature, indicating that excitation of sympathetic preganglionic neurons
was responsible for the cardiovascular restoration. Note: Without stimulation, self-reported symptoms of pre-syncope were severe, being
between 6 and 9, whereas with stimulation symptoms were completely abrogated. Participant reported that cognitive processing was so
slow in the upright position that she was ‘‘not conversational’’ until the stimulation was turned on. AIS-A, American Spinal Injury
Association Impairment Scale Grade A; BP, blood pressure; MCA, middle cerebral artery; PCA, posterior cerebral artery; vmean, mean
flow velocity; PCAvmean, mean flow velocity; SV, stroke volume; dP/dt, delta pressure over delta time (cardiac contractility); SOL,
soleus; TA, tibialis anterior; MH, medial hamstring; VL, vastus lateralis; SCG, superior cervical ganglia; SG, stellate ganglia; CG, celiac
ganglia; SMG, superior mesenteric ganglia; IMG, inferior mesenteric ganglia. Color image is available online at www.liebertpub.com/neu
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applied using a self-adhesive electrode with a diameter of 30mm
(ValueTrode) placed on the skin between TVII and TVIII spinous
processes (approximately corresponding to the T8 spinal segment)
at the midline over the vertebral column as a cathode, and two
5 · 9 cm self-adhesive electrodes (ValueTrode) located symmetri-
cally on the skin over the iliac crests as anodes. The stimulation was
delivered at 30Hz as monophasic, 1-ms pulses, to provide afferent
input to the region of the spinal cord where sympathetic pregan-
glionic neuron cell bodies are located.7 The current was increased
from 10mA until BPwas normalized, up to a maximum 70mA, and
maintained for at least 1min. Electromyography (EMG) of the
lower-limb skeletal muscles was also recorded to confirm that
skeletal muscle contractions were not occurring and therefore the
pressor responses were not attributed to the skeletal muscle pump
of the venous vasculature.22 Bipolar surface electrodes placed bi-
laterally on the vastus lateralis (VL), rectus femoris (RF), and
medial hamstrings (MH), tibialis anterior (TA), soleus (SOL), and
medial gastrocnemius (MG) muscles with fixed interelectrode
distance of 20mm. The EMG signals were differentially amplified
using the PowerLab System (PowerLab; ADInstruments, Dunedin,
New Zealand) with a band-pass filter of 10Hz to 1 kHz. The EMG
data were digitized at a sampling rate of 4000Hz.
For each participant, brachial BP was measured (Dinamap,
General Electric Pro 300V2; General Electric Tampa, FL) on the
left brachial artery each minute throughout the protocol. Beat by
beat blood flow velocity in the middle and posterior cerebral ar-
teries (MCA, PCA; Transcranial Doppler, Spencer Technologies,
Redmond, WA) and BP (Finometer PRO; Finapres Medicine
Systems, Amsterdam, The Netherlands) were recorded and col-
lected as previously described.20 Systolic and diastolic BP (SBP,
DBP), as well as peakMCA blood velocity and PCA blood velocity
(MCAv, PCAv) and minimum MCAv/PCAv, were then extracted
from three time points: 1) supine rest (at least 10–15 sec of con-
tinuous resting data); 2) the three heart beats corresponding to
minimum BP during the orthostatic challenge; and 3) during 10–
15 sec of stable BP during transcutaneous stimulation. From these
FIG. 2. Cardiovascular, cardiac, and cerebrovascular responses to orthostatic challenge were normalized with transcutaneous elec-
trical spinal cord stimulation. (A) Blood pressure responses were normalized with stimulation. (B) Cerebral blood flow was normalized
with stimulation. (C) Although systolic function in terms of contractility (dP/dt) was normalized with stimulation, heart rate was still
elevated and stroke volume was not restored. (D) Symptoms of orthostatic intolerance were almost completely abrogated with stim-
ulation. Repeated-measures ANOVA with Bonferoni contrasts. #p= 0.07; *p < 0.05; **p< 0.01; ***p < 0.001. ANOVA, analysis of
variance; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood pressure; MCA, middle cerebral artery;
PCA, posterior cerebral artery; vmean, mean flow velocity; PCAvmean, mean flow velocity; SV, stroke volume; HR, heart rate; Q,
cardiac output; TPR, total peripheral resistance. Color image is available online at www.liebertpub.com/neu
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values, mean arterial pressure (MAP) as (2*DBP+SBP)/3 and
mean MCAv/PCAv as (2*MCAv/PCAv minimum+MCAv/PCAv
maximum)/3 were calculated. Stroke volume, cardiac output,
and cardiac contractility (dP/dt) were calculated from the BP
waveform with the Modelflow method, incorporating age, sex,
height, and weight (BeatScope 1.0 software; TNO TPD Biomedical
Instrumentation, Milan, Italy).23 Cardiac output (Q) was calculated
as stroke volume (SV)*heart rate (HR). Total peripheral resistance
(TPR) was calculated as MAP/Q. All hemodynamic variables were
assessed using a one-way repeated measures analysis of variance
(ANOVA) with Bonferroni contrast tests between time points
(supine, orthostatic challenge, and orthostatic challenge with
stimulation). Significance was set a priori at p< 0.05.
Results
A clinical vignette is presented in Figure 1, demonstrating the
integrated cardiovascular and cerebrovascular benefits of transcu-
taneous spinal cord stimulation. All participants experienced clini-
cally defined OH, which was abrogated with stimulation at the TVII
level (Figure 2); however, lower-limb skeletalmuscle contraction did
not occur, obviating the possibility that the pressor response was
attributed to skeletal muscle pump action.24 Heart rate did not de-
crease with stimulation leading SV to still be reduced (Fig. 2).
Discussion
Electrical stimulation of the spinal cord, applied transcuta-
neously, can improve autonomic cardiovascular function after
SCI. Specifically, transcutaneous electrical stimulation of the tho-
racic spinal cord completely abrogated orthostatic hypotension
within 60 sec of application. This astonishing and clinically rele-
vant finding was not accompanied by lower-limb skeletal muscle
contraction, indicating that the elevations in BP were not attributed
to the skeletal muscle pump returning venous blood to the arterial
heart, but rather excitation of sympathetic pre-ganglionic neurons
leading to vasoconstriction (see Fig. 3). The clinical implications of
these realizations are broad and profound, and will be discussed
further below.
Crucially, the symptoms of orthostatic intolerance, such as
nausea and dizziness, were mitigated or completely abolished with
stimulation. An unexpected finding of the present data is that heart
rate remained elevated during stimulation despite a restored BP and
ensuing baroreflex loading.18,25 It may be that stimulation was
reaching levels in the spinal cord where cardiac sympathetic pre-
ganglionic neurons are located, because we know that the activity
of sympathetic interneurons extend much further after SCI.26
Potential mechanisms
Electrical spinal cord stimulation applied noninvasively nor-
malized autonomic cardiovascular dysfunction presenting as OH,
as assessed in the present study. After BP, cerebral blood flow, and
cardiac function declined drastically with the orthostatic challenge,
the stimulation effectively restored these integrated responses to
levels observed in the supine position before stimulation. The
mechanism through which transcutaneous electrical stimulation
elicits integrated cardiovascular benefits was not directly assessed
in the present study, and has never been examined. There are at
least two possible mechanisms underlying the noted improvements
in cardiovascular control. Both of these scenarios depend on
sympathetic pre-ganglionic neuron excitation, leading to increased
vascular tone, and hence elevations of BP, cerebral perfusion, etc.
The first is that primarily small caliber C-fiber afferents may have
been excited, which has been reported to elicit uncontrolled ex-
aggerated and often prolonged overactivity of propriospinal inter-
neurons that receive aberrantly elevated sensory input after SCI and
lack appropriate supraspinal inhibition to cease excitation once it
has occurred (i.e., autonomic dysreflexia27–30). The resulting
characteristic excitation of pre- and ganglionic neurons, if this was
the case, however, would be progressively severe and would result
in uncontrolled elevations in BP, and we would expect heart rate to
decrease during the dysreflexia period.7,11,17 Alternatively, that we
observed controlled and stable steady-state increases in BP sug-
gests that propriospinal and sympathetic preganglionic neurons are
being excited either directly through the stimulation reaching the
spinal cord or by preferential excitation of large diameter sensory
axons that do not commonly elicit autonomic dysreflexia.31
In support of this, we know that transcutaneous stimulation can
recruit the same neural structures as direct epidural stimulation,32
which is recognized to heavily involve propriospinal inter-
neurons.33,34 Further to this, the elevation in heart rate suggests that
the excitatory stimuli is reaching neurons at least at the T4 spinal
segments, where cell bodies of cardiac preganglionic neurons are
located, which almost certainly requires interneuron excitation.7,35
In fact, we know that the excitation of sympathetic preganglionic
neurons located several levels rostrally from where the stimulation
site is likely, considering that intraspinal sympathetic pathways
undergo plastic changes after SCI. Thus, afferent stimuli could
enter the spinal cord and reflexively excite preganglionic neurons
located a number of spinal segments rostrally.26 The specific testing
of these mechanisms is outside of the scope of this article.
FIG. 3. Theoretical framework. Thoracic level stimulation using
transcutaneous electrical stimulation excites dorsal afferents that
likely excited intersegmental and intrasegmental neurons, which
directly and indirectly lead to depolarization of sympathetic pre-
ganglionic neurons leading to increased vascular tone. RVLM,
rostral ventrolateral medulla. Color image is available online at
www.liebertpub.com/neu
ELECTRICAL STIMULATION CARDIOVASCULAR SCI 449
Perspectives
The present data may represent the dawning of a new era where
autonomic cardiovascular function can be robustly controlled in a
safe and tolerable manner. Certainly, the present data suggest that a
noninvasive neuroprosthetic device using electrical stimulation to
modulate the spinal cord may be a viable new nonpharmacological
option to provide a precise and robust strategy to control and/or
facilitate effective autonomic function. Its impact could be rapid
given the need for new clinical options for managing OH in those
living with SCI. In addition, other conditions, such as multiple
sclerosis, postural orthostatic tachycardia syndrome, and intrame-
dullary astrocytoma, may benefit with a similar interventional
strategy.7,36 The potential impact of the implications of the present
results is magnified further given that midodrine is considered to be
a key front-line pharmacological tool, but the U.S. Food and Drug
Administration (FDA) has recently proposed suspending its ap-
proval because of lack of clinical evidence.7 Recently, droxidopa
was approved by the FDA for managing OH; however, because this
drug readily crosses the blood–brain barrier, the use of droxidopa in
those with altered neurological activity and adrenergic sensitivity
could lead to unexpected side effects.37 Very recently, a servo-
controlled compression device was shown to mitigate the severity
of OH, highlighting the interest in utilizing neuroprosthetics as a
complimentary therapy to starndard pharmacological interventions
for managing this condition.38
In the present form, we conservatively chose to limit the duration
of the stimulation because of the (remote) possibility of overheating
the skin.39 The logical next steps are to evaluate the role of more
direct spinal cord stimulation either through intraspinal or epidural
implants, and to examine whether repetitive electrical stimulation
(invasive and noninvasive) of spinal cord circuitry can neuroreh-
abilitate autonomic function, which has been previously suggested.40
Another future direction is to determine whether transcutaneous
neuromodulation can be used to reduce the severity of transient
hypertensive episodes (termed autonomic dysreflexia) after SCI, by
modulating the excitability of sympathetic pre-ganglionic neurons.41
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